Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

NCT05049473 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Mature B-Cell Leukemia Burkitt Type
Burkitt Lymphoma (BL)
Unclassifiable Lymphoma Between DCBL and BL

Interventions

DRUG: Rituximab
DRUG: Methotrexate
DRUG: Dexamethasone
DRUG: Iphosphamid
DRUG: Vincristine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vindesine
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Prednisone

Sponsor

PETHEMA Foundation

Collaborators

[object Object]